Brief: Pulse Biosciences Announces Positive Clinical Data On Nano-Pulse Stimulation Procedure For Low-Risk Basal Cell Carcinoma Lesions
06/10/2022 13:40
Oct 6 (Reuters) - Pulse Biosciences Inc PLSE.O :
* PULSE BIOSCIENCES ANNOUNCES POSITIVE CLINICAL DATA ON
NANO-PULSE
STIMULATION PROCEDURE FOR LOW-RISK BASAL CELL CARCINOMA LESIONS
Source text for Eikon: ID:nBwb9yj3pa
Further company coverage: PLSE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Pulse Biosciences
See all newsBrief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants
Chairmen Total Approximately $13.3 Million
Pulse Biosciences records Q1 revenue, but loss widens on higher clinical investment
Brief: Pulse Biosciences Q1 Net Income USD -18.581 Million
Brief: Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System